Gargoylism

From WikiMD's Food, Medicine & Wellness Encyclopedia

Gargoylism also known as Hurler's syndrome or Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder characterized by a deficiency of a specific enzyme required to break down molecules called glycosaminoglycans.

Symptoms[edit | edit source]

The symptoms of Gargoylism typically become apparent within the first year or two of life. These may include abnormal bone development, coarse facial features, clouded corneas, heart disease, hearing loss, hydrocephalus, hernia, joint stiffness and mental retardation.

Causes[edit | edit source]

Gargoylism is caused by mutations in the IDUA gene. This gene provides instructions for producing an enzyme that is involved in the breakdown of large sugar molecules called glycosaminoglycans. Mutations in the IDUA gene reduce or completely eliminate the function of this enzyme, leading to the accumulation of glycosaminoglycans in the body's cells.

Diagnosis[edit | edit source]

Diagnosis of Gargoylism is based on a thorough clinical evaluation, a detailed patient history, and specialized tests such as enzyme analysis or molecular genetic testing.

Treatment[edit | edit source]

There is currently no cure for Gargoylism. Treatment is directed toward the specific symptoms that are apparent in each individual. This may include physical therapy for joint stiffness, surgery for bone abnormalities, and enzyme replacement therapy to slow the progression of the disease.

Prognosis[edit | edit source]

The prognosis for individuals with Gargoylism varies. Some individuals have a severe form of the disorder and live only into early childhood, while others have a milder form and live into adulthood.

See also[edit | edit source]

References[edit | edit source]

Gargoylism Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD